Fabhalta 200 MG
Ended Awarded
- Contract number
- 36C24526N0145
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $33,838
Award facts
- Contract value 100% obligated
- $33,838.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cary, NC 27513, USA
Award details come from SAM.gov/FPDS.
About this award
Novartis Pharmaceuticals Corporation, doing business as NPS, was awarded a $33,838.23 firm fixed-price delivery order for FABHALTA 200 MG by Veterans Integrated Service Network 5 (VISN 5), a component of the Department of Veterans Affairs. The contract, with an ultimate completion date of November 21, 2025, was issued without a small business set-aside designation. The place of performance is located in Cary, North Carolina. This delivery order is placed against Novartis' existing Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), which enables the VA to procure pharmaceutical products from the company's established schedule pricing and terms.
As a leading pharmaceutical manufacturer specializing in advanced medical treatments, Novartis has established itself as a significant supplier to the VA and other federal healthcare systems. The company holds substantial indefinite delivery vehicles with federal agencies, including a $7.48 million Blanket Purchase Agreement with VA's Integrated Service Network 10 and a $26.1 billion ceiling Indefinite Delivery Contract with the Defense Health Agency. This VISN 5 delivery order represents a component of the broader federal procurement of specialty pharmaceuticals, consistent with Novartis' portfolio of cancer therapies and specialized medical treatments delivered to support veteran healthcare initiatives.
Quick answers
Who was awarded contract 36C24526N0145?
36C24526N0145 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 5 (Veterans Health Administration) on November 12, 2025.
How much is contract 36C24526N0145 worth?
The government has obligated $33,838 on 36C24526N0145.
Is contract 36C24526N0145 an order under another contract?
Yes. 36C24526N0145 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0145 competed?
The extent of competition for 36C24526N0145 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award